FDA DrugClass IIINotable
FDA Recall: Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Via
Description
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
Hazard
Labeling: Not Elsewhere Classified. The carton for Eptifibatide Injection 75 mg/100 mL states 75 mg/100 mL vial for weight-adjusted bolus dosing. The approved statement is 75 mg/100 mL vial for weight-adjusted infusion.
Remedy
N/A
Related Recalls
2026-06-17 · FDA_DRUG
FDA Recall: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile,
SUN PHARMACEUTICAL INDUSTRIES INC
2026-06-17 · FDA_DRUG
FDA Recall: Duloxetine Delayed-Release Capsules, USP, 30mg, 1000 Capsule bottles, Rx only, Manufactured. by: Tow
Breckenridge Pharmaceutical, Inc.
2026-06-17 · FDA_DRUG
FDA Recall: GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured
Golden State Medical Supply Inc.
2026-06-17 · FDA_DRUG
FDA Recall: Primidone Tablets, USP, 50 mg, 100 Tablets per Bottle, Rx only, Manufactured by: Amneal Pharmaceutic
Amneal Pharmaceuticals, LLC